Yokohama, Japan

Shoji Nishiyama


Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 101(Granted Patents)


Location History:

  • Kanagawa, JP (1997)
  • Kanagawa-ken, JP (2001)
  • Yokohama, JP (1992 - 2006)

Company Filing History:


Years Active: 1992-2006

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Shoji Nishiyama

Introduction

Shoji Nishiyama is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of triterpene derivatives for the treatment of liver diseases. With a total of 11 patents to his name, Nishiyama's work has garnered attention in both academic and commercial sectors.

Latest Patents

One of Nishiyama's latest patents focuses on triterpene derivatives and remedies for liver diseases. This patent discloses a triterpene derivative that is useful for treating hepatic disorders. The compound comprises an active ingredient represented by a specific formula, where various groups can be substituted to enhance its therapeutic efficacy. This innovative approach highlights Nishiyama's commitment to addressing critical health issues through his research.

Career Highlights

Throughout his career, Nishiyama has worked with notable companies such as Shiseido Company, Limited and Meiji Seika Kaisha, Ltd. His experience in these organizations has allowed him to apply his inventive skills in practical settings, contributing to advancements in pharmaceutical products.

Collaborations

Nishiyama has collaborated with esteemed colleagues, including Kenzo Ito and Kazue Sasaki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shoji Nishiyama's contributions to the field of medicinal chemistry are noteworthy, particularly his work on triterpene derivatives for liver diseases. His extensive patent portfolio and collaborations with industry leaders underscore his impact on the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…